Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy

par Pettengell, R., Schwenkglenks, M., Bosly, A.
Publié 2008

Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland

par SCHMUTZ, C., MÄUSEZAHL, D., BLESS, P. J., HATZ, C., SCHWENKGLENKS, M., URBINELLO, D.
Publié dans Epidemiol Infect (2017)

IMPLEMENTATION OF A NURSE-LED COMMUNITY CARE PROGRAM FOR SENIOR CITIZENS IN BASELLAND (CH): THE INSPIRE PROJECT

par Deschodt, M, Blozik, E, Briel, M, Probst-Hensch, N, Quinto, C, Schwenkglenks, M, Zeller, A, De Geest, S
Publié dans Innov Aging (2018)

Are weak or negative clinical recommendations associated with higher geographical variation in utilisation than strong or positive recommendations? Cross-sectional study of 24 heal...

par Ulyte, Agne, Wei, Wenjia, Gruebner, Oliver, Bähler, Caroline, Brüngger, Beat, Blozik, Eva, von Wyl, Viktor, Schwenkglenks, M, Dressel, Holger
Publié dans BMJ Open (2021)

Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy—findings from clinical practice

par Krzemieniecki, K., Sevelda, P., Erdkamp, F., Smakal, M., Schwenkglenks, M., Puertas, J., Trojan, A., Szabo, Z., Bendall, K., Maenpaa, J.
Publié 2013

Planning and reporting of quality-of-life outcomes in cancer trials

par Schandelmaier, S., Conen, K., von Elm, E., You, J. J., Blümle, A., Tomonaga, Y., Saccilotto, R., Amstutz, A., Bengough, T., Meerpohl, J. J., Stegert, M., Olu, K. K., Tikkinen, K. A. O., Neumann, I., Carrasco-Labra, A., Faulhaber, M., Mulla, S. M., Mertz, D., Akl, E. A., Sun, X., Bassler, D., Busse, J. W., Ferreira-González, I., Lamontagne, F., Nordmann, A., Gloy, V., Raatz, H., Moja, L., Rosenthal, R., Ebrahim, S., Vandvik, P. O., Johnston, B. C., Walter, M. A., Burnand, B., Schwenkglenks, M., Hemkens, L. G., Bucher, H. C., Guyatt, G. H., Briel, M., Kasenda, B.
Publié dans Ann Oncol (2016)